6-methyl-2-phenyl-2,6-dihydro-1,3,6,2-dioxazaborocine-4,8-diol, 98%, 5g

3-(1h-Indol-2-yl)propanoic acid, 98%, 1g

7-Bromo-1-heptanol>88.0%(GC)1g

2-Chloro-5-(difluoromethoxy)pyrimidine, 97.0%, 25g

2-Bromomethyl-6-methoxy-benzo[b]thiophene, 95.0%, 1g

5-Hydroxy-2-methoxybenzoic acid, 95.0%, 1g

Hydroxypropyl Acrylate (mixture of 2-Hydroxypropyl and 2-Hydroxy-1-methylethyl Acrylate) (stabilized with MEHQ)>90.0%(GC)25mL

4-(3-Carboxy-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 1g

18 mm Medium Wall Precision NMR Sample Tube 8" L, 350MHz, 1ea

Methyl 2-bromo-3-phenylpropanoate, 95.0%, 1g

2-Chloro-4-(propan-2-yloxy)aniline, 95+%, 100mg

3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-5-(4-fluorophenyl)-1,4-dihydro-4-oxo-, 99%, 5mg

1,4-DIOXASPIRO[4.5]DEC-8-YLIDENEACETONITRILE, 95.0%, 250mg